Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

The Effect of Aquaporin 2 Gene Variations on Plasma Levels of von Willebrand Factor and Factor VIII and on the Risk of Venous Thrombosis.

Anne Yael Nossent, MSc, Johanne H. Ellenbroek, Bsc, Marijke Frolich, PhD, Frits R. Rosendaal, Md PhD, Rogier M. Bertina, PhD, Nine V.A.M. Knoers, Md PhD, Jeroen C.J. Eikenboom, Md PhD

Blood (2007) 110 (11): 1749.

https://doi.org/10.1182/blood.V110.11.1749.1749

Published: 2007

Journal Articles

Coagulation Factors, Postmenopausal Hormone Replacement Therapy and the Risk of Venous Thrombosis: The WHI Clinical Trials of Postmenopausal Hormone Therapy.

Mary Cushman, MD, MSc, Joseph Larson, MSc, Frits R. Rosendaal, MD, PhD, Lawrence S. Phillips, MD, Barbara V. Howard, PhD, J. David Curb, MD, Jennifer Hays-Grudo, PhD, Alison Baird, MD, PhD, Charles B. Eaton, MD, Susan R. Heckbert, MD, PhD, Randall S. Stafford, MD, PhD

Blood (2007) 110 (11): 127.

https://doi.org/10.1182/blood.V110.11.127.127

Published: 2007

Journal Articles

Hypofibrinolysis as a Risk Factor for Venous Thrombosis.

Mirjam E. Meltzer, MSc, Carine J.M. Doggen, PhD, Philip G. de Groot, PhD, Frits R. Rosendaal, MD, PhD, Ton Lisman, PhD

Blood (2006) 108 (11): 272.

https://doi.org/10.1182/blood.V108.11.272.272

Published: 2006

Journal Articles

Reduced Plasma Fibrinolytic Potential Is a Risk Factor for Venous Thrombosis.

Ton Lisman, PhD, Philip G. de Groot, PhD, Jelle Adelmeijer, BSci, Joost C.M. Meijers, PhD, Frits R. Rosendaal, MD, PhD

Blood (2004) 104 (11): 2597.

https://doi.org/10.1182/blood.V104.11.2597.2597

Published: 2004

Journal Articles

Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Antigen Levels and TAFI Gene Polymorphisms in Patients with Budd-Chiari Syndrome and Portal Vein Thrombosis.

Emile L.E. de Bruijne, MD, Sarwa D. Murad, MD, Moniek P. de Maat, MD PhD, Elizabeth B. Haagsma, MD PhD, Bart van Hoek, MD PhD, Frits R. Rosendaal, MD PhD, Harry L.A. Janssen, MD PhD, Frank W.G. Leebeek, MD PhD

Blood (2004) 104 (11): 280.

https://doi.org/10.1182/blood.V104.11.280.280

Published: 2004

NARROW

The Effect of Aquaporin 2 Gene Variations on Plasma Levels of von Willebrand Factor and Factor VIII and on the Risk of Venous Thrombosis.

Coagulation Factors, Postmenopausal Hormone Replacement Therapy and the Risk of Venous Thrombosis: The WHI Clinical Trials of Postmenopausal Hormone Therapy.

Hypofibrinolysis as a Risk Factor for Venous Thrombosis.

Reduced Plasma Fibrinolytic Potential Is a Risk Factor for Venous Thrombosis.

Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Antigen Levels and TAFI Gene Polymorphisms in Patients with Budd-Chiari Syndrome and Portal Vein Thrombosis.

Email alerts

ASH Publications

American Society of Hematology

The Effect of Aquaporin 2 Gene Variations on Plasma Levels of von Willebrand Factor and Factor VIII and on the Risk of Venous Thrombosis.

Coagulation Factors, Postmenopausal Hormone Replacement Therapy and the Risk of Venous Thrombosis: The WHI Clinical Trials of Postmenopausal Hormone Therapy.

Hypofibrinolysis as a Risk Factor for Venous Thrombosis.

Reduced Plasma Fibrinolytic Potential Is a Risk Factor for Venous Thrombosis.

Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Antigen Levels and TAFI Gene Polymorphisms in Patients with Budd-Chiari Syndrome and Portal Vein Thrombosis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only